| language |
eng
|
| Author |
Shigematsu Takashi
Department of Nephrology, Wakayama Medical University, 811-1 Kimiidera, Wakayama-City, Wakayama, 641-8509, Japan
Muraoka Ryoichi
Data Science Group, Clinical Development Department, EA Pharma Co., Ltd, Tokyo, Japan
Nishizawa Yoshiki
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan
|
| Subject | Chronic kidney disease (CKD); Bone disease; Osteoporosis; Biomarkers; Calcium; Treatment
|
| Journal Title |
BMC NEPHROLOGY
|
| Volume | 18
|
| ISSN | 1471-2369
|
| Published Date | 2017-02-15
|
| DOI | |
| PubMed ID | |
| Publisher | BIOMED CENTRAL LTD
|
| NII Type |
Journal Article
|
| OAI-PMH Set |
Faculty of Medicine
|
| Remark | This study was supported by the Joint Development Program of EA Pharma Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Funding for writing/editorial support was provided by EA Pharma Co., Ltd.
|
